News . Data . Research
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that works to accelerate the development and commercialization of discoveries from research universities and
Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, reported financial results for the third quarter
Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As part of
Medical technology company Becton, Dickinson, and Company (NYSE: BDX) announced results for the final three months of fiscal 2023. Fourth-quarter revenue increased
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023. Revenue was
Biogen Inc. (NASDAQ: BIIB) reported third quarter 2023 earnings results today. Total revenue rose 1% year-over-year to $2.53 billion. Revenues grew 3%
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of 2023. Revenues
Medical technology company Zimmer Biomet Holdings, Inc. (NYSE: ZBH) on Tuesday reported an increase in third-quarter sales and adjusted profit. Third-quarter net
Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The company also
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, has reported financial results for the third quarter of 2023. The
Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third quarter of
Eli Lilly and Company (NYSE: LLY) reported third quarter 2023 earnings results today. Worldwide revenue was $9.50 billion, up 37% compared to
The Cigna Group (NYSE: CI) reported third quarter 2023 earnings results today. Total revenues increased 8% to $49 billion compared to the same
IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported
CVS Health Corporation (NYSE: CVS) reported third quarter 2023 earnings results today. Total revenues increased 10.6% year-over-year to $89.8 billion. Net income
Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday, after the company delivered lackluster results for the third quarter of 2023.
Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023. The company
Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company reported a
Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also provided guidance
Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period a year
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced third-quarter 2023 financial results, reporting lower revenues and net income. The company reported